Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
sales of 34.71 billion Euro [US$37.52 billion]
of which 84%
(48.88 billion Swiss Francs [US$49.17 billion]
of which 66%
was innovative medicines), and
based in Germany
(46.77 billion Euro [US$50.56 billion]
of which 35%
was Pharmaceuticals & Biological Products).
Roche Holding Aktiengesellschaft reported sales of 50.58 billion Swiss Francs (US$50.88 billion)
December of 2016.
increase of 5.0%
versus 2015, when the company's sales were 48.15 billion Swiss Francs.
Sales at Roche Holding Aktiengesellschaft have increased during each of the previous five years
(and since 2011, sales have increased a total of 19%).
Sales of Diagnostics saw an increase
6.1% in 2016, from
10.81 billion Swiss Francs to 11.47 billion Swiss Francs.